Anne Marie Bickmore is COO and Chief Product Officer of Health Catalyst, Inc.. Currently has a direct ownership of 63,720 shares of HCAT, which is worth approximately $439,668. The most recent transaction as insider was on Dec 01, 2023, when has been sold 4,114 shares (Common Stock) at a price of $7.45 per share, resulting in proceeds of $30,649. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 63.7K
0% 3M change
0% 12M change
Total Value Held $439,668

Anne Marie Bickmore Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 01 2023
SELL
Payment of exercise price or tax liability
$30,649 $7.45 p/Share
4,114 Reduced 6.06%
63,720 Common Stock
Sep 01 2023
SELL
Payment of exercise price or tax liability
$19,813 $11.78 p/Share
1,682 Reduced 2.42%
67,834 Common Stock
Jun 01 2023
SELL
Payment of exercise price or tax liability
$19,726 $11.24 p/Share
1,755 Reduced 2.46%
69,516 Common Stock
May 03 2023
BUY
Grant, award, or other acquisition
-
35,000 Added 32.93%
71,271 Common Stock
AMB

Anne Marie Bickmore

COO and Chief Product Officer
South Jordan, UT

Track Institutional and Insider Activities on HCAT

Follow Health Catalyst, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Insider Trading

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

News

Receive news related to Health Catalyst, Inc.

Track Activities on HCAT